OCS
OCULIS HOLDING N (OCS)
NASDAQ
$11.89+$0.22 (+1.89%)
Price as of Jun 23, 2026 1:35 PM EDT
  • $791.1M
    Market Cap
  • -40.61%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-57.1M
+9.60%
-52.1M
+78.08%
-29.2M
+31.60%
-22.2M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
25.8M
+18.25%
21.8M
+24.70%
17.5M
+58.05%
11.1M
N/A
Operating Profit
-81.7M
+11.57%
-73.2M
-9.30%
-80.7M
+149.30%
-32.4M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-54,000
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
+100.00%
-54,000
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
54,000
N/A
Income before Taxes
-99.0M
+15.37%
-85.8M
-3.41%
-88.8M
+129.47%
-38.7M
N/A
Income Taxes
-186,000
+16.25%
-160,000
-249.53%
107,000
+94.55%
55,000
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-99.0M
+15.37%
-85.8M
-3.41%
-88.8M
+129.47%
-38.7M
N/A
Net Income from Continuing Operations Applicable to Common
-99.0M
+15.37%
-85.8M
-3.41%
-88.8M
+129.47%
-38.7M
N/A
Basic EPS and Net Income
-1.89
-10.85%
-2.12
-28.62%
-2.97
-77.05%
-12.94
N/A
Diluted EPS and Net Income
-1.89
-10.85%
-2.12
-28.62%
-2.97
-77.05%
-12.94
N/A
Basic Weighted Average Shares
52.2M
+29.29%
40.4M
+35.14%
29.9M
+900.18%
3.0M
N/A
Diluted Weighted Average Shares
52.2M
+29.29%
40.4M
+35.14%
29.9M
+900.18%
3.0M
N/A
Balance Sheet
Cash and Cash Equivalents
81.3M
+193.52%
27.7M
-27.71%
38.3M
+93.71%
19.8M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
81.3M
+193.52%
27.7M
-27.71%
38.3M
+93.71%
19.8M
N/A
Total Current Assets
218.9M
+108.67%
104.9M
+3.84%
101.0M
+327.00%
23.7M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
534,000
+38.70%
385,000
+33.68%
288,000
-21.10%
365,000
N/A
Total Long-Term Assets
17.1M
+10.47%
15.5M
+15.88%
13.3M
-0.48%
13.4M
N/A
Total Assets
236.0M
+96.06%
120.4M
+5.25%
114.4M
+208.56%
37.1M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
36.7M
-16.93%
44.2M
+131.74%
19.1M
+58.80%
12.0M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
3.1M
+15.03%
2.7M
+77.94%
1.5M
-98.75%
123.0M
N/A
Total Liabilities
39.9M
-15.07%
47.0M
+127.73%
20.6M
-84.73%
135.1M
N/A
Retained Earnings
-384.5M
+34.65%
-285.6M
+42.94%
-199.8M
+80.02%
-111.0M
N/A
Total Stockholders Equity
196.1M
+167.19%
73.4M
-21.71%
93.7M
+195.65%
-98.0M
N/A
Total Shares Outstanding
58.7M
-9.16%
64.6M
+76.27%
36.6M
+975.79%
3.4M
N/A
Cash Flow
Cash from Operating Activities
-66.3M
+39.59%
-47.5M
-11.79%
-53.8M
+114.74%
-25.1M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-60.9M
+247.06%
-17.6M
-67.61%
-54.2M
+1,427.93%
-3.5M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
186.9M
+245.95%
54.0M
-58.33%
129.7M
+7,465.46%
1.7M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-55.54%
-24.01%
-73.09%
-37.69%
-117.30%
N/A
N/A
N/A
Return on Equity
-73.45%
-28.45%
-102.66%
-102.46%
4,166.17%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
5.96
+151.18%
2.37
-55.19%
5.29
N/A
N/A
N/A
Cash Ratio
2.21
+253.32%
0.63
-68.80%
2.01
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow